Masimo Corporation (MASI)

Market Cap	7.87B
Revenue (ttm)	2.15B
Net Income (ttm)	-459.20M
Shares Out	54.32M
EPS (ttm)	-8.54
PE Ratio	n/a
Forward PE	26.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	888,293
Open	146.23
Previous Close	144.65
Day's Range	144.28 - 148.08
52-Week Range	107.98 - 194.88
Beta	1.21
Analysts	Buy
Price Target	189.00 (+30.44%)
Earnings Date	Aug 5, 2025

About AGR

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arter...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2007
• Employees: 3,600
• Stock Exchange: NASDAQ
• Ticker Symbol: MASI
• Website: https://www.masimo.com

Analyst Summary

According to 6 analysts, the average rating for MASI stock is "Buy." The 12-month stock price target is $189.0, which is an increase of 30.44% from the latest price.

Price Target

$189.0

(30.44% upside)

Analyst Consensus: Buy